851095-32-4 Usage
Description
STX-0119, also known as N-[5-(2-Furanyl)-1,3,4-oxadiazol-2-yl]-2-phenyl-4-quinolinecarboxamide, is a small molecular inhibitor of STAT3. It is a cancer therapeutic agent specifically targeting Glioblastoma multiforme tumor cells and serves as a promising drug target in the field of oncology.
Uses
Used in Oncology:
STX-0119 is used as a cancer therapeutic agent for targeting STAT3, a protein that plays a crucial role in the development and progression of various cancers, including Glioblastoma multiforme. By inhibiting STAT3, STX-0119 aims to suppress tumor growth and improve patient outcomes.
Used in Drug Development:
STX-0119 is used as a drug target in the development of novel cancer therapies. Its ability to inhibit STAT3 makes it a valuable candidate for the creation of new drugs that can effectively combat cancer cells and enhance the efficacy of existing treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 851095-32-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,1,0,9 and 5 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 851095-32:
(8*8)+(7*5)+(6*1)+(5*0)+(4*9)+(3*5)+(2*3)+(1*2)=164
164 % 10 = 4
So 851095-32-4 is a valid CAS Registry Number.
851095-32-4Relevant articles and documents
STAT3 INHIBITOR CONTAINING QUINOLINECARBOXAMIDE DERIVATIVE AS ACTIVE INGREDIENT
-
, (2011/06/24)
The present invention provides a STAT3 inhibitor containing as an active ingredient, a quinolinecarboxamide derivative represented by the formula (I) (in the formula, W represents a bond or an alkylene chain; X represents O, S, or NR34; and Rs
